UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome Journal article
HAO, DP, LI, JJ, WANG, JL, ZHAO, ZQ, Wang, L., Di, L.. Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome[J]. Theranostics, 2019, 3952-3965.
Authors:  HAO, DP;  LI, JJ;  WANG, JL;  ZHAO, ZQ;  Wang, L.; et al.
Favorite |   IF:12.4/12.0 | Submit date:2023/08/30
Ovarian cancer  Estrogen signaling  Deficiency of homologous-recombination  Chemotherapy  Hormone replacement  
CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling Journal article
Zhao, ZQ, Hao, DP, Wang, L., LI, JJ, MENG, Y, LI, PP, WANG, Y, ZHANG, C, ZHOU, HS, GARDNER, K, Di, L.. CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling[J]. Oncogene, 2018, 1-16.
Authors:  Zhao, ZQ;  Hao, DP;  Wang, L.;  LI, JJ;  MENG, Y; et al.
Favorite |   IF:6.9/7.5 | Submit date:2023/08/30
CtBP  Cholesterol  Metastasis